Breaking News

CatSci Opens New Site in UK

Strengthens analytical capabilities with the opening of a secondary site in Dagenham backed by a $4.2 million investment.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

CatSci, an innovation partner for medicines development, is expanding its capabilities in material science, analytical science and pre-formulation studies to better serve its customers’ needs. This expansion will be supported by an approximately $4.2 million investment over the next two years and the opening of a secondary site in Dagenham, Essex, UK, in April 2021. The new facility will help to increase the UK’s scientific exports and solidify the UK as a center for excellence in pharmaceutical...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters